We suspected that immunosuppressive therapy could inhibit BAFF expression and that higher serum BAFF levels might exist in NMO patients without treatment during remission, which would indicate persistent humoral immune dysfunction. This evidence concerns the gene TNFSF13B and neuromyelitis optica.